Adverse events
CAVITY, ACUTE ENDOPHTHALMITIS
Acute endophthalmitis was observed in none of the study eyes. TA was inadvertently injected into the vitreous cavity of 2.2% (There was no significant IOP rising which needed medical or surgical treatment (over 10, 25 or 30 mmHg) observed in any of the participants. The mean IOP respectively obtained as 14.9 ± 2.7, 15 ± 1.9 and 15.5 ± 2.2 mmHg at baseline and after four and twelve weeks in the monotherapy arm and as 15.3 ± 3.2, 16 ± 3.1 and 16.1 ± 2.6 mmHg in the combination arm. There was no significant IOP rising noticed in each groups during the study period (Table 